Adial Pharmaceuticals, Inc.ADILNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year book value per share growth
Latest
-61.39%
↓ 701% vs avg
Percentile
P8
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
10.22%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -61.39% |
| Q2 2025 | 360.02% |
| Q1 2025 | -47.72% |
| Q4 2024 | -78.29% |
| Q3 2024 | -1.40% |
| Q2 2024 | -50.66% |
| Q1 2024 | -15.58% |
| Q4 2023 | 23.68% |
| Q3 2023 | -32.30% |
| Q2 2023 | 115.55% |
| Q1 2023 | -55.68% |
| Q4 2022 | -41.61% |
| Q3 2022 | -35.78% |
| Q2 2022 | -29.21% |
| Q1 2022 | 170.67% |
| Q4 2021 | -52.90% |
| Q3 2021 | 32.13% |
| Q2 2021 | -22.23% |
| Q1 2021 | 27.34% |
| Q4 2020 | -46.60% |
| Q3 2020 | -33.32% |
| Q2 2020 | 47.25% |
| Q1 2020 | -21.40% |
| Q4 2019 | -20.98% |
| Q3 2019 | -13.47% |
| Q2 2019 | -30.79% |
| Q1 2019 | 112.59% |
| Q4 2018 | -24.74% |
| Q3 2018 | 549.18% |
| Q2 2018 | 27.64% |
| Q1 2018 | -50.05% |
| Q4 2017 | -50.18% |
| Q3 2017 | -24.63% |
| Q2 2017 | -91.05% |
| Q1 2017 | -135.44% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |